Follow
rolf Kiessling
rolf Kiessling
Unknown affiliation
Verified email at ki.se
Title
Cited by
Cited by
Year
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
K Kärre, HG Ljunggren, G Piontek, R Kiessling
Nature 319 (6055), 675-678, 1986
28871986
„Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
R Kiessling, E Klein, H Wigzell
European journal of immunology 5 (2), 112-117, 1975
26531975
„Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell
R Kiessling, E Klein, H Pross, H Wigzell
European journal of immunology 5 (2), 117-121, 1975
16261975
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations
B Agerberth, J Charo, J Werr, B Olsson, F Idali, L Lindbom, R Kiessling, ...
Blood, The Journal of the American Society of Hematology 96 (9), 3086-3093, 2000
10202000
Heat-shock proteins as activators of the innate immune system
RPA Wallin, A Lundqvist, SH Moré, A von Bonin, R Kiessling, ...
Trends in immunology 23 (3), 130-135, 2002
7952002
Regulatory T cells in cancer
D Mougiakakos, A Choudhury, A Lladser, R Kiessling, CC Johansson
Advances in cancer research 107, 57-117, 2010
6012010
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts
R Kiessling, PS Hochman, O Haller, GM Shearer, H Wigzell, G Cudkowicz
European journal of immunology 7 (9), 655-663, 1977
5931977
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
5852014
Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
I Poschke, D Mougiakakos, J Hansson, GV Masucci, R Kiessling
Cancer research 70 (11), 4335-4345, 2010
4952010
An analysis of the murine NK cell as to structure, function and biological relevance.
R Kiessling, H Wigzell
4591979
Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated …
K Kono, F Salazar‐Onfray, M Petersson, J Hansson, G Masucci, ...
European journal of immunology 26 (6), 1308-1313, 1996
4301996
Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression.
M Matsuda, F Salazar, M Petersson, G Masucci, J Hansson, P Pisa, ...
The Journal of experimental medicine 180 (6), 2371-2376, 1994
4241994
Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
H Nakagomi, M Petersson, I Magnusson, C Juhlin, M Matsuda, ...
Cancer research 53 (23), 5610-5612, 1993
4241993
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo
O Haller, M Hansson, R Kiessling, H Wigzell
Nature 270 (5638), 609-611, 1977
3501977
Tumor-induced immune dysfunction
R Kiessling, K Wasserman, S Horiguchi, K Kono, J Sjöberg, P Pisa, ...
Cancer immunology, immunotherapy 48, 353-362, 1999
3361999
Circulating heat shock protein 60 is associated with early cardiovascular disease
AG Pockley, R Wu, C Lemne, R Kiessling, U de Faire, J Frostegård
Hypertension 36 (2), 303-307, 2000
3242000
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ...
Cancer research 67 (3), 1317-1325, 2007
3222007
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ...
The Journal of Immunology 183 (8), 4921-4930, 2009
3122009
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
P Pisa, E Halapi, EK Pisa, E Gerdin, C Hising, A Bucht, B Gerdin, ...
Proceedings of the National Academy of Sciences 89 (16), 7708-7712, 1992
3111992
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity
Y Mao, D Sarhan, A Steven, B Seliger, R Kiessling, A Lundqvist
Clinical cancer research 20 (15), 4096-4106, 2014
3082014
The system can't perform the operation now. Try again later.
Articles 1–20